Director Johan Christenson resigns from Aprea Therapeutics board

Aprea Therapeutics, Inc.

Johan Christenson, M.D., Ph.D. resigned from the Board of Directors effective upon filing of Q3 2021 Form 10-Q.
Resignation is not due to any disagreement with the company's operations, policies, or practices.
No replacement director has been announced yet.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Johan Christenson

Director

APRE · Aprea Therapeutics, Inc.

Filed: October 15, 2021, 7:59 PM ET

On October 13, 2021, Johan Christenson, M.D., Ph.D. resigned from the Board of Directors of the Company, effective upon the Company’s filing of its Form 10-Q for the third quarter of 2021.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Johan Christenson resigned as Director at Aprea Therapeutics, Inc..

Action: resigned
Role: Director

Exact text from the filing

On October 13, 2021, Johan Christenson, M.D., Ph.D. resigned from the Board of Directors of the Company, effective upon the Company’s filing of its Form 10-Q for the third quarter of 2021.

View on SEC.gov

Aprea Therapeutics, Inc. filing history →

Source: SEC EDGAR

accession 0001104659-21-126763

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.